Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CEST

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
08/21 LIGAND PHARMACEUTICALS INCORPORATED : LGND) Files An 8-K Departure of Directors..
08/21 LIGAND PHARMACEUTICALS INC : Change in Directors or Principal Officers, Regulati..
08/21 LIGAND PHARMACEUTICALS : to Receive $2 Million from WuXi Biologics for Licensing..
08/21 LIGAND PHARMACEUTICALS : Appoints Dr. Nancy Gray to its Board of Directors
08/18 LIGAND PHARMACEUTICALS : to Receive $2 Million from WuXi Biologics for Licensing..
08/09 LIGAND PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
08/09 LIGAND PHARMACEUTICALS : Reports second quarter 2017 financial results
08/07 LIGAND PHARMACEUTICALS : posts 2Q profit
08/07 LIGAND PHARMACEUTICALS INCORPORATED : LGND) Files An 8-K Results of Operations ..
08/07 LIGAND PHARMACEUTICALS INC : Results of Operations and Financial Condition (form..
More news
News from SeekingAlpha
08/22 LIGAND : Situated For Growth
08/12 LIGAND PHARMACEUTICALS : A Lot Of Growth Potential At A Reasonable Price
08/07 Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q2 2017 Results - Earnings..
08/07 Ligand Pharmaceuticals beats by $0.21, beats on revenue
08/06 Notable earnings after Monday?s close